Autologous bone marrow-derived nucleated cell (aBMNC) transplantation improves endometrial function in patients with refractory Asherman's syndrome or with thin and dysfunctional endometrium
dc.authorscopusid | 31767766600 | en_US |
dc.authorwosid | CDM-6595-2022 | en_US |
dc.contributor.author | Arıkan, Gürkan | |
dc.contributor.author | Turan, Volkan | |
dc.contributor.author | Kürek Eken, Meryem | |
dc.contributor.author | Göksoy, Hasan Sami | |
dc.contributor.author | Doğusan, Zeynep | |
dc.date.accessioned | 2023-01-22T13:58:23Z | |
dc.date.available | 2023-01-22T13:58:23Z | |
dc.date.issued | 2023 | en_US |
dc.department | Fakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kadın Hastalıkları ve Doğum Ana Bilim Dalı | en_US |
dc.description.abstract | Purpose: The purpose was to evaluate the effect of intrauterine injection of aBMNC on the endometrial function in patients with refractory Asherman's syndrome (AS) and/or thin and dysfunctional endometrium (TE). Study design: This is a prospective, experimental, non-controlled study MATERIAL AND METHODS: The study was carried out between December 2018 and December 2020 on 20 patients, who were of age < 45 years and had oligo/amenorrhea and primary infertility due to refractory AS and/or TE. One hundred ml BM was extracted. aBMNC cells were separated according to generic volume reduction protocol by using the Cell Separation System SEPAX S-100 table top centrifuge system. We have evaluated CD34+, mononuclear cell (MNC), and total nucleated cell (TNC) counts. The transplantation aBMNC was performed by two intrauterine injections at an interval of one week, transvaginally into the endometrial-myometrial junction by an ovum aspiration needle. Midcyclic endometrial thickness (ET) and gestations after transplantation were evaluated. Results: The mean TNC, MNC, and CD34+ cells were 11.55 ± 4.7 × 108, 3.85 ± 2.01 × 108, and 7.00 ± 2.88 × 106 at first injection, respectively, and 6.85 ± 2.67 × 108, 2.04 ± 1.11 × 108, and 3.44 ± 1.31 × 106 at second injection, respectively. The maximum posttransplantation ET was significantly higher than the maximum pretransplantation ET: 2.97 ± 0.48 vs. 5.76 ± 1.19 (mean ± standard deviation, p < 0.01). Twelve patients had frozen-thaw embryo transfers after the study. In 42% (n = 5 of 12) of the patients, pregnancy was achieved. One of the five patients delivered a healthy baby at term. Conclusions: Autologous BMNC transplantation may contribute to endometrial function in patients with AS and/or TE. | en_US |
dc.identifier.citation | Arıkan, G., Turan, V., Kürek Eken, M., Göksoy, H. S. & Doğusan, Z. (2023). Autologous bone marrow-derived nucleated cell (aBMNC) transplantation improves endometrial function in patients with refractory Asherman's syndrome or with thin and dysfunctional endometrium. Journal of Assisted Reproduction and Genetics, 40(5), pp. 1163-1171. https://doi.org/10.1007/s10815-023-02727-w | en_US |
dc.identifier.doi | 10.1007/s10815-023-02727-w | en_US |
dc.identifier.endpage | 1171 | en_US |
dc.identifier.issn | 1058-0468 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | PMID: 36662355 | en_US |
dc.identifier.scopus | 2-s2.0-85146584085 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 1163 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s10815-023-02727-w | |
dc.identifier.uri | https://hdl.handle.net/20.500.13055/377 | |
dc.identifier.volume | 40 | en_US |
dc.identifier.wos | WOS:000917974100001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak.other | SCI-E - Science Citation Index Expanded | en_US |
dc.institutionauthor | Turan, Volkan | |
dc.language.iso | en | en_US |
dc.publisher | Springer Nature | en_US |
dc.relation.ispartof | Journal of Assisted Reproduction and Genetics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Asherman’s Syndrome | en_US |
dc.subject | Autologous Bone Marrow | en_US |
dc.subject | Endometrium | en_US |
dc.subject | Stem Cells | en_US |
dc.subject | Thin Endometrium | en_US |
dc.subject | Total Nucleated Cells | en_US |
dc.title | Autologous bone marrow-derived nucleated cell (aBMNC) transplantation improves endometrial function in patients with refractory Asherman's syndrome or with thin and dysfunctional endometrium | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |
Dosyalar
Orijinal paket
1 - 1 / 1
Kapalı Erişim
- İsim:
- Autologous bone marrow-derived nucleated cell (aBMNC) transplantation improves endometrial function in patients with refractory Asherman’s syndrome or with thin and dysfunctional endometriumm.pdf
- Boyut:
- 1.07 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text
Lisans paketi
1 - 1 / 1
Kapalı Erişim
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: